No megamergers, but healthcare deals up in Q2: PwC
There were about 281 health services deals in the second quarter, which is down 7.3% compared to the same quarter last year but up compared to the first quarter of this year, according to a new report from PwC. (Getty/peterspiro)
The overall number of deals in the healthcare sector rose more than 7% in the second quarter compared to earlier this year, according to a new report from PwC.
However, there were no megadeals, and total deal volume in the second quarter was $15 billion, down about 40% compared to the same quarter of 2018 and down about 51% compared to the first quarter.
There were about 281 deals, which is down 7.3% compared to the same quarter last year. It is the eighth quarter in a row with more than 250 deals.
Key drivers of deal activity include tax reform impact, inpatient volume pressure, cross-industry deals and vertical integration and the evolution of technology.
